DRG Market Assessment Reports

Report November 3, 2021

Irritable Bowel Syndrome – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of IBS comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of IBS for each country, as well as…

north_east

Report November 3, 2021

Non-Alcoholic Fatty Liver Disease – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key NAFLD patient populations, covering 171 countries and more than 99…

north_east

Report November 3, 2021

Irritable Bowel Syndrome – Epidemiology – Europe

north_east

Report November 3, 2021

Irritable Bowel Syndrome – Epidemiology – Americas

north_east

Report November 1, 2021

Achromatopsia – Epidemiology – Mature Markets Data

Clarivate Epidemiology’s coverage of achromatopsia (ACHM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…

north_east

Report October 21, 2021

PD-L1 – Epidemiology – Mature Markets

Clarivate Epidemiology has created a robust repository of the prevalence of biomarker- and mutation-defined treatment-eligible cancer populations. Using Clarivate’s Biomarker Epidemiology, you…

north_east

Report October 18, 2021

Atrial Fibrillation – Epidemiology – Americas Data

Clarivate Epidemiology’s coverage of atrial fibrillation (AF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AF for each…

north_east

Report October 18, 2021

Retinal Vein Occlusion – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of retinal vein occlusion (RVO) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RVO for…

north_east

Report October 18, 2021

Retinal Vein Occlusion – Epidemiology – Asia-Pacific

Clarivate Epidemiology’s coverage of retinal vein occlusion (RVO) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RVO for…

north_east

Report October 18, 2021

Retinal Vein Occlusion – Epidemiology – Europe

Clarivate Epidemiology’s coverage of retinal vein occlusion (RVO) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RVO for…

north_east

Report October 18, 2021

Retinal Vein Occlusion – Epidemiology – Americas

Clarivate Epidemiology’s coverage of retinal vein occlusion (RVO) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of RVO for…

north_east

Report October 15, 2021

Hereditary Angioedema – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of hereditary angioedema (HAE) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of HAE for each country,…

north_east

Product logins

DRG Market Assessment reports

Irritable Bowel Syndrome – Epidemiology – Middle East & Africa

Non-Alcoholic Fatty Liver Disease – Epidemiology – Extrapolated Worldwide Coverage

Irritable Bowel Syndrome – Epidemiology – Europe

Irritable Bowel Syndrome – Epidemiology – Americas

Achromatopsia – Epidemiology – Mature Markets Data

PD-L1 – Epidemiology – Mature Markets

Atrial Fibrillation – Epidemiology – Americas Data

Retinal Vein Occlusion – Epidemiology – Middle East & Africa

Retinal Vein Occlusion – Epidemiology – Asia-Pacific

Retinal Vein Occlusion – Epidemiology – Europe

Retinal Vein Occlusion – Epidemiology – Americas

Hereditary Angioedema – Epidemiology – Middle East & Africa

Follow us

Contact us